First-in-class oral non-peptide GLP-1 receptor agonist (small molecule, not peptide-derived) with oral bioavailability. Activates GLP-1 receptors on brainstem vagal afferents and hypothalamic appetite neurons to signal satiety, reduce hunger-promoting NPY/AgRP neuron activity, and suppress ghrelin secretion. Simultaneously activates pancreatic beta-cell GLP-1R for glucose-dependent insulin secretion and slows gastric emptying. Provides comparable weight loss to injectable GLP-1 agonists with convenient once-daily oral dosing.
Take orally once daily in the morning, 30 min before first meal. Titrate: 12mg x2wk → 24mg x2wk → 36mg. Significant advantage over injectable alternatives.
Log doses, calculate reconstitution, set reminders, and get AI guidance for Orforglipron.
Start Free Trial